Summary & Overview
CPT 77261: Clinical Treatment Planning for Radiation Therapy
CPT code 77261 is a foundational billing code in radiation oncology, representing clinical treatment planning for radiation therapy using both external and internal sources. This code is essential for documenting the initial phase of radiation treatment, where physicians assess patient-specific factors and develop a tailored plan to ensure optimal outcomes. The service is most commonly performed in outpatient settings, including hospital outpatient departments and freestanding cancer centers.
Nationally, CPT 77261 is recognized by major payers such as Aetna, Blue Cross Blue Shield, Cigna Health, Medicare, and UnitedHealthcare. Its widespread adoption underscores its importance in the delivery of cancer care, particularly for patients diagnosed with malignant neoplasms of the breast, prostate, lung, colon, and brain. The code is part of a series that includes related codes for intermediate and complex planning, reflecting the varying levels of clinical complexity involved in radiation treatment planning.
Readers will gain insight into the clinical context of CPT 77261, payer coverage, and its role in the broader landscape of radiation oncology billing. The publication provides benchmarks, policy updates, and an overview of associated diagnoses and related codes, equipping stakeholders with a comprehensive understanding of this critical component of cancer care reimbursement.
CPT Code Overview
CPT 77261 represents clinical treatment planning for radiation therapy using external and internal sources. This code is utilized in the field of radiation oncology to document the initial planning phase required before delivering radiation treatment to patients. The service typically occurs in outpatient radiation oncology settings, such as hospital outpatient departments or freestanding cancer centers. The planning process involves evaluating patient-specific factors and determining the appropriate approach for radiation delivery, ensuring safe and effective treatment.
Clinical & Coding Specifications
Clinical Context
A patient diagnosed with a malignant neoplasm, such as breast cancer (C50.911), prostate cancer (C61), lung cancer (C34.90), colon cancer (C18.9), or brain cancer (C71.9), is referred to an outpatient radiation oncology facility. The radiation oncology physician evaluates the patient and determines the need for external or internal radiation therapy. The clinical workflow involves gathering diagnostic imaging, reviewing the patient's medical history, and developing a basic radiation treatment plan. This plan outlines the target area, dose, and technique, and is documented as part of the clinical treatment planning process represented by CPT code 77261.
Coding Specifications
-
Modifiers:
- Modifier
26: Used to indicate the professional component of the service, typically when the physician provides the clinical planning but does not own the equipment. - Modifier
TC: Used to indicate the technical component, typically when the facility provides the equipment and technical staff for the service.
- Modifier
-
Provider Taxonomies:
| Taxonomy Code | Specialty Name |
|---|---|
| 2085R0001X | Radiation Oncology Physician |
| 2085N0700X | Nuclear Medicine Physician |
| 2085B0100X | Body Imaging Physician |
These specialties are qualified to perform and bill for clinical treatment planning in radiation oncology.
Related Diagnoses
-
C50.911- Malignant neoplasm of unspecified site of right female breast- Relevant for patients undergoing radiation treatment planning for breast cancer.
-
C61- Malignant neoplasm of prostate- Used for patients receiving radiation therapy for prostate cancer.
-
C34.90- Malignant neoplasm of unspecified part of unspecified bronchus or lung- Applicable for lung cancer cases requiring radiation treatment planning.
-
C18.9- Malignant neoplasm of colon, unspecified- Used for colon cancer patients being considered for radiation therapy.
-
C71.9- Malignant neoplasm of brain, unspecified- Relevant for brain cancer patients needing radiation treatment planning.
Each diagnosis code represents a type of cancer commonly managed with radiation therapy, making them clinically relevant to CPT code 77261 for treatment planning.
Related CPT Codes
-
77262- Clinical Treatment Planning (External and Internal Sources) for Radiation Treatment (intermediate complexity)- Used when the treatment planning requires moderate complexity, such as additional imaging or more detailed dosimetry compared to
77261.
- Used when the treatment planning requires moderate complexity, such as additional imaging or more detailed dosimetry compared to
-
77263- Clinical Treatment Planning (External and Internal Sources) for Radiation Treatment (complex planning)- Used for cases requiring complex planning, such as multiple target volumes, advanced techniques, or extensive documentation.
These codes (77262, 77263) are alternatives to 77261 and are selected based on the complexity of the clinical treatment planning. Only one of these codes is typically billed per treatment plan, depending on the level of complexity.
National Reimbursement Benchmarks
Medicare's national mean rate for CPT code 77261 is $71.78, which is notably lower than the BUCA (Blue Cross Blue Shield, UnitedHealth Group, Cigna, Aetna) commercial average of $99.86. Among commercial payers, Cigna and UnitedHealth Group have the highest mean rates, both exceeding $113, while Aetna is the lowest at $76.47.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies significantly across payers. Medicare exhibits the tightest range at $4.00, indicating minimal variation in rates. In contrast, Cigna shows the widest dispersion at $61.00, followed by UnitedHealth Group at $56.00 and Blue Cross Blue Shield at $44.17. This suggests greater variability in commercial payer reimbursement compared to Medicare.
The table and chart below present the full breakdown of national benchmarks for CPT code 77261 across all major payers.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.